There are 2949 resources available
Tracking the recent advances within the field of unresectable HCC
Presenter: David Pinato
Session: F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
Resources:
Webcast
Reviewing the latest phase III efficacy data for unresectable HCC
Presenter: Andrew Zhu
Session: F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
Resources:
Webcast
Exploring key safety data for cancer immunotherapy combinations
Presenter: Philippe Merle
Session: F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
Resources:
Webcast
Moving into the clinic: how will these data inform our clinical decisions?
Presenter: Arndt Vogel
Session: F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
Resources:
Webcast
Faculty Q&A and Take-Home Messages
Presenter: Jennifer Sutton
Session: PeerVoice - Extending overall survival in nmCRPC while maintaining quality of life: Can we have it all?
Resources:
Webcast
Looking to the future: How can emerging therapeutic options influence the management landscape?
Presenter: Benjamin Besse
Session: Janssen - Intrinsic and acquired resistance to EGFR TKIs: New therapies on the horizon
Resources:
Webcast
Live Q&A - 18 September 2020 - 15:30-16:00
Presenter: Pilar Garrido
Session: Janssen - Intrinsic and acquired resistance to EGFR TKIs: New therapies on the horizon
Resources:
Webcast
How to ensure optimal treatment for patients with residual disease
Presenter: Andrew Wardley
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast
Summary and close
Presenter: Eva Ciruelos
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast
Optimizing treatment strategies in first-line mCRC
Presenter: Mark Saunders
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast